Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19Cell, 2021-01, Vol.184 (1), p.169-183.e17 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.11.029 ;PMID: 33296701Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionThe Journal of infectious diseases, 2021-02, Vol.223 (2), p.197-205 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa618 ;PMID: 33535236Full text available |
|
3 |
Material Type: Article
|
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Cell, 2020-11, Vol.183 (5), p.1367-1382.e17 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.10.043 ;PMID: 33160446Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial VirusCell, 2019-03, Vol.176 (6), p.1420-1431.e17 [Peer Reviewed Journal]2019 The Author(s) ;Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved. ;2019 The Author(s) 2019 ;ISSN: 0092-8674 ;ISSN: 1097-4172 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2019.01.046 ;PMID: 30849373Full text available |
|
5 |
Material Type: Article
|
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesCell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077Full text available |
|
6 |
Material Type: Article
|
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticleNature communications, 2019-09, Vol.10 (1), p.4272-17, Article 4272 [Peer Reviewed Journal]2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-12080-1 ;PMID: 31537780Full text available |
|
7 |
Material Type: Article
|
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceProceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (38) [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Sep 21, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2106845118 ;PMID: 34493582Full text available |
|
8 |
Material Type: Article
|
Discovery and engineering of enhanced SUMO protease enzymesThe Journal of biological chemistry, 2018-08, Vol.293 (34), p.13224-13233 [Peer Reviewed Journal]2018 © 2018 Lau et al. ;2018 Lau et al. ;2018 Lau et al. 2018 Lau et al. ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.RA118.004146 ;PMID: 29976752Full text available |
|
9 |
Material Type: Article
|
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER regionPLoS pathogens, 2022-05, Vol.18 (5), p.e1010518-e1010518 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Schoeder et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Schoeder et al 2022 Schoeder et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1010518 ;PMID: 35584193Full text available |
|
10 |
Material Type: Article
|
Design and immunological evaluation of two-component protein nanoparticle vaccines for East Coast feverFrontiers in immunology, 2023-01, Vol.13, p.1015840-1015840 [Peer Reviewed Journal]Copyright © 2023 Lacasta, Kim, Kepl, Gachogo, Chege, Ojuok, Muriuki, Mwalimu, Touboul, Stiber, Poole, Ndiwa, Fiala, King and Nene. ;Copyright © 2023 Lacasta, Kim, Kepl, Gachogo, Chege, Ojuok, Muriuki, Mwalimu, Touboul, Stiber, Poole, Ndiwa, Fiala, King and Nene 2023 Lacasta, Kim, Kepl, Gachogo, Chege, Ojuok, Muriuki, Mwalimu, Touboul, Stiber, Poole, Ndiwa, Fiala, King and Nene ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2022.1015840 ;PMID: 36713406Full text available |
|
11 |
Material Type: Article
|
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in micenpj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518Full text available |
|
12 |
Material Type: Article
|
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domainsProceedings of the National Academy of Sciences - PNAS, 2023-03, Vol.120 (11), p.e2214556120-e2214556120 [Peer Reviewed Journal]Copyright National Academy of Sciences Mar 14, 2023 ;Copyright © 2023 the Author(s). Published by PNAS. 2023 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2214556120 ;PMID: 36888664Full text available |
|
13 |
Material Type: Article
|
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19The Journal of immunology (1950), 2021-05, Vol.206 (1_Supplement), p.62-62.06 [Peer Reviewed Journal]ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.206.Supp.62.06Full text available |
|
14 |
Material Type: Article
|
Discovery and engineering of enhanced SUMO protease enzymesThe Journal of biological chemistry, 2018-08, Vol.293 (34) [Peer Reviewed Journal]ISSN: 0021-9258 ;EISSN: 1083-351XFull text available |
|
15 |
Material Type: Article
|
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceCell Reports, 2022-08, Vol.40 (9), p.111299-111299, Article 111299 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.111299 ;PMID: 35988541Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumovirusesImmunity (Cambridge, Mass.), 2023-10, Vol.56 (10), p.2425 [Peer Reviewed Journal]ISSN: 1097-4180 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2023.08.011Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityNature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199Full text available |
|
18 |
Material Type: Patent
|
폴리펩타이드 및 그 용도Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virusinfo:eu-repo/semantics/OpenAccess ;ISSN: 0092-8674 ;EISSN: 1097-4172Full text available |
|
20 |
Material Type: Article
|
Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challengeCell reports. Medicine, 2022-06, Vol.3 (6), p.100658, Article 100658 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100658 ;PMID: 35705092Full text available |